Hedge Fund Drops Million: Beam Biotech Bet Right Now
A major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
Tax efficiency in dividend ETFs comes from efficient distributions and holdings. Grasp the basics to maximize after-tax returns in your plan.
17,061 articlesA major hedge fund just plowed a substantial stake into a gene-editing company, signaling conviction in Beam Therapeu...
AI is rewriting investing playbooks. This piece uncovers a prophetic phrase from IBM and shows how it can inform smar...
A major stake in Kymera Therapeutics highlights growing investor optimism in targeted protein degradation. This artic...
As a looming recession tests crypto narratives, Bitcoin’s fixed supply and growing institutional interest face off ag...
Investors are asking if one AI leader can justify a multibillion-dollar market cap shift. This guide breaks down what...
A potential rollback of steel and aluminum tariffs could reshape costs for major beverage makers and packaging firms....
HYPE breaks above $57 as a short squeeze pushes the token within 2% of its all-time high, with negative funding and s...
Prices stay higher than a few years ago, eroding cash savings. A trio of ETFs—GLD, VTIP, and DBC—are positioned to he...
When big funds hold IonQ, retail investors often assume a sure bet. The reality is more nuanced: ownership data refle...
XRP's price stays below $1.40 even as CME-listed futures surpass $63 billion in notional in their first year. Traders...
Memory chips sit at the heart of AI infrastructure. As demand climbs, investors ask if will memory giants micron can ...
Nvidia just stunned investors with a blowout earnings report. As the stock vaults higher, you may wonder: should nvid...